-
Mashup Score: 0BPS Publications - 2 year(s) ago
There is international interest for consensus advice for prescribers working in the field of drug resistant epilepsy intending to trial potential therapies that are nonregistered or off-label. Cannab…
Categories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0BPS Publications - 2 year(s) ago
Aim To grade the evidence from published meta-analyses of randomized controlled trials (RCTs) that assessed effects of pharmacist intervention on cardiovascular risk factors and cardiovascular outco…
Categories: Cardiologists, Latest HeadlinesTweet-
"Pharmacist intervention can provide a wide range of benefits in cardiovascular disease management, ranging from risk factor control, improvement in medication adherence and in some setting, reduction in morbidity and mortality" https://t.co/BKTqwhl3Y0 https://t.co/dix364MlgI
-
-
Mashup Score: 1BPS Publications - 2 year(s) ago
Click on the article title to read more.
Categories: Cardiologists, Latest HeadlinesTweet-
https://t.co/u5bxceXzqH “Triple anti thrombotic therapy & dual therapy- what is the evidence base?” by ACF Dr Hani Essa from @NIHRCRN_nwcoast @LiverpoolCCS under able guidance of Dr @lozzenger1983 @LivHospitals @livuniHLS @NIHRCRF_Lpool @LivHPartners @BritishCardioSo @ShrillaB https://t.co/KnTiTwEA3x
-
-
Mashup Score: 2BPS Publications - 2 year(s) ago
Background Higher medication anticholinergic burden is associated with increased risk of cardiovascular disease and cognitive decline. A mechanistic pathway has not been established. We aimed to det…
Categories: Cardiologists, Latest HeadlinesTweet-
Congratulations to Ria Sanghavi and @tiberiupana - our work using EPIC-NORFOLK suggests higher anticholinergic burden from meds is associated with ⬆️ in markers of inflammation- may mediate relationship between anticholinergic meds and adverse outcomes https://t.co/9kLauwilyp
-
-
Mashup Score: 0BPS Publications - 2 year(s) ago
Aims Patients with advanced urothelial carcinoma (UC) who progress after platinum-based chemotherapy have a poor prognosis, and there is a medical need to improve current treatment options. Ramuciru…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Exposure-response relationship of ramucirumab in RANGE #bladdercancer @MyUniSR @SanRaffaeleMI https://t.co/tbmCtF7Lsa
-
-
Mashup Score: 1BPS Publications - 2 year(s) ago
Aims The aim of this study was to assess the incidence, nature, preventability and severity of adverse drug events (ADEs) across three paediatric intensive care units (PICUs) in England. Methods A…
Categories: General Medicine Journals and Societies, Latest HeadlinesTweet-
This multicentre study by @SoulimanAnwar & team investigates the extent to which children are harmed by medications in pediatric intensive care units. >> https://t.co/CuPgBdJT9x #OpenAccess @BritJClinPharm @BritPharmSoc @RichardKeers @MedsSafety @meds_safety https://t.co/2OVspXG5CS
-
-
Mashup Score: 3BPS Publications - 2 year(s) ago
Background Chronic inflammation is a risk factor for cardiovascular disease. IL-6 signaling perturbation through IL-6 or IL-6R blockade may have potential benefit on cardiovascular risk. It is unkno…
Categories: Cardiologists, Latest HeadlinesTweet-
Our genetic study led by @ArjenJCupido A.F. Schmidt suggests that inhibiting IL6 and IL6R may both reduce cardiometabolic disease risk but IL6 inhibition may be more optimal from an infectious disease standpoint https://t.co/ohY9iCb8vo @BritJClinPharm https://t.co/Ul5xfERiIb
-
-
Mashup Score: 0BPS Publications - 2 year(s) ago
Technologies and Tools Driving Forward GPCR Research Call for Papers: Technologies and Tools Driving Forward GPCR Research British Journal of Pharmacology will be publishing a special ‘Themed Issue’ entitled: Technologies and Tools Driving Forward GPCR Research, with Dr Shannon O’Brien and Dr Brian Hudson as Guest Editors. In this issue on,…
Categories: General Medicine Journals and Societies, Latest HeadlinesTweet-
📢 Call for papers! British Journal of Pharmacology @BrJPharmacol invites submissions for a themed issue entitled Technologies and Tools Driving Forward #GPCR Research. Submissions deadline: January 22, 2022 Find out more: https://t.co/iX1Z2epZ5O @BritPharmSoc https://t.co/pObFImZGLv
-
-
Mashup Score: 0BPS Publications - 2 year(s) ago
Technologies and Tools Driving Forward GPCR Research Call for Papers: Technologies and Tools Driving Forward GPCR Research British Journal of Pharmacology will be publishing a special ‘Themed Issue’ entitled: Technologies and Tools Driving Forward GPCR Research, with Dr Shannon O’Brien and Dr Brian Hudson as Guest Editors. In this issue on,…
Categories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Call for papers! British Journal of Pharmacology @BrJPharmacol invites submissions for a themed issue entitled Technologies and Tools Driving Forward #GPCR Research. ⏰ Submissions deadline: January 22, 2022 Find out more: https://t.co/965hVJgAUB @BritPharmSoc https://t.co/jG7wEApnjU
-
-
Mashup Score: 1BPS Publications - 2 year(s) ago
Mineralocorticoid receptor (MR) antagonists (MRAs) are key agents in guideline-oriented drug therapy for cardiovascular (CV) diseases such as chronic heart failure with reduced ejection fraction (HFr…
Categories: Cardiologists, Latest HeadlinesTweet-
📂 https://t.co/94XgpDKAdp
-
Researchers from across Australia have developed interim consensus advice for prescribers for cannabis-based medications to help treat drug resistant #epilepsy. Read more in @BritJClinPharm: https://t.co/JDsefdStdh #MedicinalCannabis @BritPharmSoc https://t.co/6BMwVanVET